|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
230,290,000 |
Market
Cap: |
138.17(K) |
Last
Volume: |
11,847,187 |
Avg
Vol: |
11,814,278 |
52
Week Range: |
$0.0001 - $0.066 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Endo International is a holding company. Through its subsidiaries, Co. is engaged in specialty pharmaceuticals. Co.'s segments are: Branded Pharmaceuticals, which includes branded products to treat and manage conditions in the areas of urology, orthopedics, endocrinology and bariatrics, among others; Sterile Injectables, which consists of branded sterile injectable products; Generic Pharmaceuticals, which includes generic product families that treat and manage a range of medical conditions; and International Pharmaceuticals, which includes products serving therapeutic areas, including attention deficit hyperactivity disorder, pain, women's health, oncology and transplantation.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Upadhyay Suketu |
EVP, Chief Financial Officer |
|
2014-02-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(20,491) |
0 |
|
- |
|
Montague William P |
Director |
|
2014-02-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,515) |
0 |
|
- |
|
Montague William P |
Director |
|
2014-02-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(20,878) |
0 |
|
- |
|
Hutson Nancy J |
Director |
|
2014-02-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,515) |
0 |
|
- |
|
Hutson Nancy J |
Director |
|
2014-02-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(20,483) |
0 |
|
- |
|
Higgins Arthur J |
Director |
|
2014-02-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,016) |
0 |
|
- |
|
Farhat Camille |
President, AMS, Inc. |
|
2014-02-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(18,128) |
0 |
|
- |
|
Farhat Camille |
President, AMS, Inc. |
|
2014-02-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,854) |
0 |
|
- |
|
Farhat Camille |
President, AMS, Inc. |
|
2014-02-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(23,589) |
0 |
|
- |
|
Farhat Camille |
President, AMS, Inc. |
|
2014-02-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,031) |
0 |
|
- |
|
Degolyer Donald W |
Chief Operating Officer,Pharma |
|
2014-02-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(40,846) |
0 |
|
- |
|
Degolyer Donald W |
Chief Operating Officer,Pharma |
|
2014-02-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(35,725) |
0 |
|
- |
|
Manogue Caroline B |
Exec. V.P., CLO & Secy |
|
2014-02-27 |
4 |
D |
$79.82 |
$80,538 |
D/D |
(1,009) |
65,397 |
|
- |
|
Gergel Ivan |
EVP, R&D and CSO |
|
2014-02-27 |
4 |
D |
$79.82 |
$72,556 |
D/D |
(909) |
27,649 |
|
- |
|
Rudio Daniel |
Vice President, Controller |
|
2014-02-27 |
4 |
D |
$79.82 |
$20,035 |
D/D |
(251) |
2,084 |
|
- |
|
Farhat Camille |
President, AMS, Inc. |
|
2014-02-27 |
4 |
D |
$79.82 |
$19,077 |
D/D |
(239) |
4,031 |
|
- |
|
Manogue Caroline B |
Exec. V.P., CLO & Secy |
|
2014-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
4,781 |
22,112 |
|
- |
|
Manogue Caroline B |
Exec. V.P., CLO & Secy |
|
2014-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
9,563 |
53,270 |
|
- |
|
Manogue Caroline B |
Exec. V.P., CLO & Secy |
|
2014-02-26 |
4 |
D |
$78.30 |
$702,586 |
D/D |
(8,973) |
64,427 |
|
- |
|
Manogue Caroline B |
Exec. V.P., CLO & Secy |
|
2014-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
5,866 |
73,400 |
|
- |
|
Gergel Ivan |
EVP, R&D and CSO |
|
2014-02-26 |
4 |
D |
$78.30 |
$712,922 |
D/D |
(9,105) |
26,564 |
|
- |
|
Gergel Ivan |
EVP, R&D and CSO |
|
2014-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
6,658 |
35,669 |
|
- |
|
Upadhyay Suketu |
EVP, Chief Financial Officer |
|
2014-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
5,073 |
20,491 |
|
- |
|
Upadhyay Suketu |
EVP, Chief Financial Officer |
|
2014-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
10,147 |
25,565 |
|
- |
|
Rudio Daniel |
Vice President, Controller |
|
2014-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
802 |
4,745 |
|
- |
|
825 Records found
|
|
Page 2 of 33 |
|
|